Frontotemporal Degeneration (FTD) and Amyotrophic Lateral Sclerosis (ALS)

Rosa Rademakers, Ph.D., and Tania Gendron, Ph.D. lead the research on frontotemporal degeneration (FTD) and amyotrophic lateral sclerosis (ALS) in the Discovery and Translation Labs at Mayo Clinic. This research centers on the novel causal genes and genetic risk factors for early-onset dementias and related disorders to improve the diagnosis and treatment of people with these diseases.